As far as 'better' is concerned, BIT225, already proven safe in immune compromised individuals, if fully proven and tested, has the potential to be extremely low cost and very easy and fast to move into a productivity and be distributed on a world scale.
If BIT can prove this in its latest trials, then they have a chance of getting it picked up by BP.
Unfortunately, the amount of research going on, may mean that BIT won't e alone delivering this result. Therein lies a danger point for BIT.
Ann: Bit225 Covid-19 Human Study Commenced, page-140
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
